Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - October 2003

  1. Granier, H.; Nicolas, X.; Laborde, J. P.; Talarmin, F.  [Severe Autoimmune Thrombopenia Following Anti-Influenza Vaccination].   Presse Med.  32 (26): 1223-1224; August 9, 2003.

  2. Modrzejewski, K. A.; Provost, G. P.  Pharmacists' Involvement With Vaccinations Leads to Preventive Health Care Role.   Am J Health Syst Pharm.  60 (17): 1724, 1726, 1728; September 1, 2003.

  3. Public Health Dispatch: Measles Epidemic--Majuro Atoll, Republic of the Marshall Islands, July 13-September 13, 2003.   MMWR Morb.Mortal.Wkly.Rep.  52 (37): 888-889; September, 2003.

  4. Decline in Annual Incidence of Varicella--Selected States, 1990-2001.   MMWR Morb.Mortal.Wkly.Rep.  52 (37): 884-885; September, 2003.

  5. Fulginiti, V. A.  Risks of Smallpox Vaccination.   JAMA.  290 (11): 1452; September 17, 2003.

  6. Paranavithana, S.; Gunasekera, D. P.  A Case of Kawasaki Disease With Reaction at a DPT Vaccination Scar Site.   Ceylon Med J.  48 (2): 62; June, 2003.

  7. Eisner, M. D.  Asthma and Influenza Vaccination.   Chest.  124 (3): 775-777; September, 2003.

  8. Gray, J.  Public Health: Bush's Smallpox Vaccination Plan.   J Law Med Ethics.  31 (2): 312-314; 2003.

  9. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on Influenza Vaccination for the 2003-2004 Season.   Can Commun Dis Rep.  29:1-20. (): 1-20; August 15, 2003.

  10. Aaby, P.; Garly, M. L.; Bale, C.; Martins, C.; Jensen, H.; Lisse, I.; Whittle, H.  Survival of Previously Measles-Vaccinated and Measles-Unvaccinated Children in an Emergency Situation: An Unplanned Study.   Pediatr Infect Dis J.  22 (9): 798-805; September, 2003.

  11. Van Den Hoven, M. A.; Verweij, M. F.  Should We Promote Influenza Vaccination of Health Care Workers in Nursing Homes? Some Ethical Arguments in Favour of Immunization.   Age Ageing.  32 (5): 487-489; September, 2003.

  12. Platonov, A. E.; Vershinina, I. V.; Kuijper, E. J.; Borrow, R.; Kayhty, H.  Long Term Effects of Vaccination of Patients Deficient in a Late Complement Component With a Tetravalent Meningococcal Polysaccharide Vaccine.   Vaccine.  21 (27-28): 4437-4447; October 1, 2003.

  13. Dannetun, E.; Tegnell, A.; Normann, B.; Garpenholt, O.; Giesecke, J.  Influenza Vaccine Coverage and Reasons for Non-Vaccination in a Sample of People Above 65 Years of Age, in Sweden, 1998-2000.   Scand.J Infect Dis.  35 (6-7): 389-393; 2003.

  14. Litt, J.; Burgess, M.  Varicella and Varicella Vaccination. An Update.   Aust.Fam.Physician.  32 (8): 583-587; August, 2003.

  15. Bourdet, S. V.; Kelley, M.; Rublein, J.; Williams, D. M.  Effect of a Pharmacist-Managed Program of Pneumococcal and Influenza Immunization on Vaccination Rates Among Adult Inpatients.   Am J Health Syst Pharm.  60 (17): 1767-1771; September 1, 2003.

  16. Ford, E. S.; Mannino, D. M.; Williams, S. G.  Asthma and Influenza Vaccination: Findings From the 1999-2001 National Health Interview Surveys.   Chest.  124 (3): 783-789; September, 2003.

  17. Tata, L. J.; West, J.; Harrison, T.; Farrington, P.; Smith, C.; Hubbard, R.  Does Influenza Vaccination Increase Consultations, Corticosteroid Prescriptions, or Exacerbations in Subjects With Asthma or Chronic Obstructive Pulmonary Disease?   Thorax.  58 (10): 835-839; October, 2003.

  18. Mills, A. E.; Murdolo, V.; Webb, S. P.  A Rare Local Granulomatous Complication of Q Fever Vaccination.   Med J Aust.  179 (3): 166; August 4, 2003.

  19. Gallwitz, S.; Schutzbank, T.; Heberling, R. L.; Kalter, S. S.; Galpin, J. E.  Smallpox: Residual Antibody After Vaccination.   J Clin Microbiol.  41 (9): 4068-4070; September, 2003.

  20. Kula, S.  Smallpox Vaccination.   Arch Dis Child.  88 (10): 841; October, 2003.

  21. Brisson, M.; Edmunds, W. J.  Varicella Vaccination in England and Wales: Cost-Utility Analysis.   Arch Dis Child.  88 (10): 862-869; October, 2003.

  22. Bellaby, P.  Communication and Miscommunication of Risk: Understanding UK Parents' Attitudes to Combined MMR Vaccination.   BMJ.  327 (7417): 725-728; September 27, 2003.

  23. Swartz, T. A.; Saliou, P.; Catznelson, E.; Blondeau, C.; Gil, I.; Peled, T.; Havkin, O.; Fletcher, M.  Immune Response to a Diphtheria and Tetanus Toxoid Administration in a Three-Dose Diphtheria Tetanus Whole-Cell Pertussis/Enhanced Inactivated Poliovirus Vaccination Schedule: A 7-Year Follow Up.   Eur J Epidemiol.  18 (8): 827-833; 2003.

  24. Teichmann, D.; Gobels, K.; Niedrig, M.; Grobusch, M. P.  Clinical and Laboratory Features of Dengue Virus-Infected Travellers Previously Vaccinated Against Yellow Fever.   Scand.J Infect Dis.  35 (6-7): 427-429; 2003.

  25. MacIntyre, C. R.; Chu, C. P.; Burgess, M. A.  Use of Hospitalization and Pharmaceutical Prescribing Data to Compare the Prevaccination Burden of Varicella and Herpes Zoster in Australia.   Epidemiol Infect.  131 (1): 675-682; August, 2003.

  26. Massoudi, M. S.; Barker, L.; Schwartz, B.  Effectiveness of Postexposure Vaccination for the Prevention of Smallpox: Results of a Delphi Analysis.   J Infect Dis.  188 (7): 973-976; October 1, 2003.

  27. Preziosi, M. P.; Halloran, M. E.  Effects of Pertussis Vaccination on Disease: Vaccine Efficacy in Reducing Clinical Severity.   Clin Infect Dis.  37 (6): 772-779; September 15, 2003.

  28. Pukhalsky, A. L.; Shmarina, G. V.; Bliacher, M. S.; Fedorova, I. M.; Toptygina, A. P.; Fisenko, J. J.; Alioshkin, V. A.  Cytokine Profile After Rubella Vaccine Inoculation: Evidence of the Immunosuppressive Effect of Vaccination.   Mediators.Inflamm.  12 (4): 203-207; 2003.

  29. Lau, C.; Sisson, J.  The Effectiveness of Intradermal Pre-Exposure Rabies Vaccination in an Australian Travel Medicine Clinic.   J Travel.Med.  9 (6): 285-288; November, 2002.

  30. Ehreth, J.  The Value of Vaccination: A Global Perspective.   Vaccine.  21 (27-28): 4105-4117; October 1, 2003.

  31. Wong, S. J.; Boyle, R. H.; Demarest, V. L.; Woodmansee, A. N.; Kramer, L. D.; Li, H.; Drebot, M.; Koski, R. A.; Fikrig, E.; Martin, D. A.; Shi, P. Y.  Immunoassay Targeting Nonstructural Protein 5 to Differentiate West Nile Virus Infection From Dengue and St. Louis Encephalitis Virus Infections and From Flavivirus Vaccination.   J Clin Microbiol.  41 (9): 4217-4223; September, 2003.

Back to Top